XINFA AN
1.Broad-spectrum protection in one shot agains four dominant epidemicstrains:IBD virus-like particles(VLPs),with good immunogenicity
2.Purer antigens obtained from a new chromatographic puificationtechnique
3.Safe,high efficacy and long-lasting efficacy
| Company Name | Sinopharm Animal Health Co., Ltd | Country/Region | China |
| Business Type | business_type_options | Company Size | 663 |
| Established | October 24, 2025 | ||
| Address | |||
| Main Products | Swine Vaccine、Pet Vaccine、Avian Vaccine、Ruminant Vaccine、Diagnostic Reagent、Theraupeutic Product、Economic Animal Vaccine | ||
Sinopharm Animal Health Co., Ltd is a backbone enterprise of China Sinopharm, a subsidiary of the Fortune Global 500 pharmaceutical companies. Our corporate mission is to prevent and control animal diseases and safeguard human health.
The company has over 20 production lines in two major production bases, Wuhan Optics Valley and Yangzhou Hanjiang, with supporting intelligent experimental animal bases. It has passed the national new version of animal medicine GMP certification,ISO 9001 ,ISO 14001 and ISO 45001 Certification, animal medicine GCP certification, and CNAS laboratory certification. The company can produce more than 80 products in seven categories including porcine vaccines, poultry vaccines, ruminant vaccines, pet vaccines, diagnostic products, therapeutic products, and economic animal vaccines. The vaccine varieties are complete, and the annual production capacity exceeds 10 billion feathers (heads). The internal control standards of the main products are higher than the national standards. It is a designated production enterprise for major animal disease vaccines in China.
The company's R&D（research and development） center is the only research platform of China Sinopharm engaged in the development of animal health related products, and is one of the six major R&D centers in China National Biotec Group Co., Ltd ，Recognized as National Center for Enterprise Technology，Key Laboratory of Animal Biological Products & Genetic Engineering, Ministry of Agriculture and Rural,P.R.China。
Sinopharm Animal Health Co., Ltd has built multiple R&D innovation platforms, where independent innovation and external introduction complement each other,It has accumulated advanced technologies, such as baculovirus expression, cell suspension culture, antigen concentration and purification, and high-throughput disease diagnosis.The company's scientific research strength is at the forefront of China's animal biological products enterprises, and it is one of the few animal health enterprises in China with the ability to create new products.
The company advocates the concept of "service marketing" and promotes integrated epidemic prevention services such as "door-to-door solution, door-to-door delivery, door-to-door immunization, and door-to-door monitoring", providing "one-stop" solutions for livestock and poultry breeding enterprises. Its sales and service network covers key livestock and poultry breeding areas across the country. The market share of multiple products such as PCV2 and SMHP Vaccine, Inactivated, CSF Vaccine, Live,PPR and GP Vaccine, Live ranks among the top in the industry. The comprehensive prevention and control services for diseases such as PED and PRRS have been highly praised by farmers.
